The global cosmetics industry is experiencing a pronounced shift toward natural and plant-based ingredients. As brands increasingly formulate with botanical extracts for cosmetics, understanding the regulatory landscape has become essential for manufacturers, formulators, and brand owners alike. Navigating these requirements is not simply a matter of compliance — it is a foundation for product safety, market access, and consumer trust.

Why Regulatory Requirements Matter for Botanical Extracts

Unlike synthetic ingredients produced under tightly controlled laboratory conditions, botanical extracts are derived from living plants. Their chemical composition can vary depending on growing region, harvest season, soil conditions, and extraction method. This natural variability, while valuable for product diversity, introduces unique challenges for regulators who must ensure that every batch is safe, consistent, and properly labeled.

Regulatory frameworks exist to address several critical concerns: the identity and purity of the extract, the absence of harmful contaminants such as heavy metals or pesticide residues, the stability of active compounds over time, and the accuracy of label claims. For botanical extract manufacturers, meeting these requirements is a continuous process that spans the entire supply chain — from raw material sourcing to final product testing.

Major Regulatory Frameworks Around the World

Regulatory requirements for botanical extracts in cosmetics vary significantly by region. Below is an overview of the most influential frameworks that shape the global market.

European ｕｎｉｏｎ: EU Cosmetics Regulation (EC) No. 1223/2009

The EU maintains one of the most comprehensive regulatory systems for cosmetic products. Under the EU Cosmetics Regulation, every cosmetic product placed on the market must undergo a safety assessment signed by a qualified safety assessor. Botanical ingredients are not subject to pre-market approval, but they must not appear on the prohibited or restricted substance lists found in Annexes II and III of the regulation.

A key requirement is the Cosmetic Product Safety Report (CPSR), which must include detailed information on the qualitative and quantitative composition of the product, the physical and chemical characteristics of each ingredient, microbiological quality, impurity traces, and toxicological data. For botanical extracts for skin care and other cosmetic applications, this means every extract must be thoroughly characterized.

The EU also enforces strict rules on preservatives, colorants, and UV filters — these substance categories require pre-authorization before use. Additionally, the EU ban on animal testing for cosmetic ingredients, in effect since 2009, means that all safety data must be generated through alternative methods such as in vitro assays and computational modeling.

United States: FDA Oversight under the FD&C Act

In the United States, the Food and Drug Administration (FDA) regulates cosmetics under the Federal Food, Drug, and Cosmetic Act (FD&C Act). Unlike the EU, the U.S. does not require pre-market approval for cosmetic products or ingredients — with the exception of color additives. However, manufacturers are legally responsible for ensuring that their products are safe when used as directed and are properly labeled.

The Modernization of Cosmetics Regulation Act (MoCRA), enacted in 2022, significantly expanded FDA authority. Key new requirements include mandatory facility registration, product listing, adverse event reporting, and the obligation to maintain safety substantiation records. For botanical extract suppliers, this means providing detailed documentation on extract specifications, manufacturing processes, and quality control data to downstream brand customers.

China: NMPA and Cosmetic Supervision and Administration Regulation (CSAR)

China has rapidly modernized its cosmetics regulatory framework. The Cosmetic Supervision and Administration Regulation (CSAR), effective since January 2021, introduced a risk-based classification system that divides cosmetics into special-use cosmetics (such as sunscreens, hair dyes, and skin whitening products) and general-use cosmetics. Botanical extracts used in general cosmetics now require simplified notification filing, while special-use cosmetics still require registration and approval from the National Medical Products Administration (NMPA).

China also mandates that cosmetic ingredients comply with the Safety and Technical Standards for Cosmetics (STSC), which sets limits for heavy metals, microbial contaminants, and restricted substances. A significant requirement for botanical raw materials is the recently issued industry standard YY/T 10002-2026, which establishes technical guidelines for plant-derived cosmetic ingredients, including safety control indicators for microbial limits, heavy metals, and other risk substances based on plant characteristics.

ASEAN and Other Key Markets

The ASEAN Cosmetic Directive (ACD) harmonizes cosmetic regulations across ten Southeast Asian nations, modeled closely after the EU framework. Japan's Pharmaceutical and Medical Device Act (PMD Act) classifies cosmetics separately from quasi-drugs, with the latter requiring pre-market approval. South Korea's Cosmetics Act, enforced by the Ministry of Food and Drug Safety (MFDS), similarly distinguishes between general cosmetics and functional cosmetics that require additional review.

Quality and Safety Testing: What Regulators Expect

Regardless of the specific regulatory framework, there are universal testing requirements that botanical extracts must meet before they can be used in cosmetic formulations. These can be grouped into four essential categories.

Identity Testing

Regulators require that every botanical extract be accurately identified to the correct plant species, plant part, and geographic origin. Advanced techniques such as High-Performance Liquid Chromatography (HPLC), DNA barcoding, and Nuclear Magnetic Resonance (NMR) spectroscopy are used to create a chemical fingerprint of the extract. Proper identification prevents substitution errors — for example, distinguishing between closely related species where one may contain toxic alkaloids.

Purity and Contaminant Testing

Botanical extracts must be tested for a range of potential contaminants. Heavy metals — including lead, arsenic, mercury, and cadmium — must fall below established threshold limits as specified in the relevant pharmacopeia or regulatory standard. Pesticide residues are screened against maximum residue limits (MRLs), and residual solvents from the extraction process must be within acceptable ranges. Microbial testing covers total aerobic plate count, yeast and mold, and specific pathogens such as Escherichia coli, Salmonella, and Staphylococcus aureus.

Potency and Standardization

For extracts marketed with a specific active compound content — such as a green tea extract standardized to a certain percentage of EGCG or a ginkgo biloba extract standardized to flavonol glycosides — regulators expect that the label claim is verified by validated analytical methods. HPLC and Ultra-Performance Liquid Chromatography (UPLC) are the most widely accepted techniques for quantifying marker compounds. Batch-to-batch consistency is also a regulatory expectation, as it ensures that the cosmetic product performs consistently over time.

Stability Testing

Stability testing demonstrates that the botanical extract maintains its specified quality parameters under defined storage conditions over its shelf life. This includes testing under accelerated conditions (elevated temperature and humidity) as well as real-time, long-term storage conditions. Parameters monitored typically include organoleptic properties, active compound content, moisture level, and microbial limits.

Key Certifications That Demonstrate Compliance

Certifications serve as a practical shorthand for buyers evaluating whether a botanical extract supplier meets regulatory requirements. The table below summarizes the most relevant certifications in the cosmetics supply chain.

The Nagoya Protocol and Access to Plant Genetic Resources

A regulatory dimension that is sometimes overlooked is the international framework governing access to plant genetic resources. The Nagoya Protocol on Access and Benefit Sharing (ABS), which entered into force in 2014, establishes that countries have sovereign rights over their genetic resources. Companies using plant materials for cosmetic ingredient development must comply with the access and benefit-sharing regulations of the source country.

In practice, this means that a cosmetic brand or extract manufacturer sourcing plants from a biodiversity-rich country must obtain Prior Informed Consent (PIC) and establish Mutually Agreed Terms (MAT) with the provider country. The benefit-sharing obligations can include monetary compensation, technology transfer, or joint research initiatives. While the Nagoya Protocol has been implemented differently across countries, leading to some fragmentation, it remains a critical compliance requirement for companies sourcing novel botanical ingredients internationally.

Choosing a Compliant Botanical Extract Supplier

For cosmetic brands and formulators, selecting the right botanical extract supplier is one of the most consequential decisions affecting regulatory compliance. Here are practical criteria to evaluate potential suppliers.

• Comprehensive documentation: The supplier should provide a Certificate of Analysis (COA) for every batch, along with a Material Safety Data Sheet (MSDS) and detailed product specifications covering identity, purity, potency, and microbiological limits.
• Third-party testing capability: Look for suppliers with in-house analytical laboratories equipped with HPLC, GC-MS, and ICP-MS instrumentation, or those who regularly use accredited third-party labs.
• Certifications portfolio: A supplier holding multiple internationally recognized certifications demonstrates a commitment to quality that goes beyond minimum regulatory requirements.
• Traceability systems: The supplier should be able to trace every batch of extract back to its botanical source, including growing region, harvest date, and extraction parameters.
• Regulatory knowledge: The supplier should understand the specific requirements of your target markets — whether that is the EU CPSR, FDA MoCRA compliance, or China's CSAR notification process.

Botaniex, with its science-driven R&D team comprising PhDs and researchers in phytochemistry and pharmacology, advanced extraction capabilities including supercritical CO₂ technology, and a global supply chain with botanical authentication protocols, is positioned to support cosmetic brands in meeting these regulatory demands. The company serves clients across North America, Europe, and Asia, and offers a diverse portfolio of standardized botanical extracts for cosmetics that are fully characterized and batch-tested for quality and safety.